Moreover, the 36-month beta value for ONVO is 0.55. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ONVO is 15.07M and currently, short sellers hold a 0.76% of that float. On January 10, 2025, ONVO’s average trading volume was 191.95K shares.
ONVO) stock’s latest price update
The stock price of Organovo Holdings Inc (NASDAQ: ONVO) has dropped by -11.59 compared to previous close of 0.49. Despite this, the company has seen a fall of -6.28% in its stock price over the last five trading days. globenewswire.com reported 2025-01-06 that SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announced that it had appointed Norman Staskey as Chief Financial Officer.
ONVO’s Market Performance
Organovo Holdings Inc (ONVO) has experienced a -6.28% fall in stock performance for the past week, with a -6.10% drop in the past month, and a -4.43% drop in the past quarter. The volatility ratio for the week is 18.33%, and the volatility levels for the past 30 days are at 13.42% for ONVO. The simple moving average for the past 20 days is 7.85% for ONVO’s stock, with a -34.95% simple moving average for the past 200 days.
Analysts’ Opinion of ONVO
Many brokerage firms have already submitted their reports for ONVO stocks, with H.C. Wainwright repeating the rating for ONVO by listing it as a “Buy.” The predicted price for ONVO in the upcoming period, according to H.C. Wainwright is $2.50 based on the research report published on December 13, 2018 of the previous year 2018.
ONVO Trading at 4.48% from the 50-Day Moving Average
After a stumble in the market that brought ONVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.23% of loss for the given period.
Volatility was left at 13.42%, however, over the last 30 days, the volatility rate increased by 18.33%, as shares sank -3.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.47% lower at present.
During the last 5 trading sessions, ONVO fell by -6.28%, which changed the moving average for the period of 200-days by -57.75% in comparison to the 20-day moving average, which settled at $0.3996. In addition, Organovo Holdings Inc saw -6.28% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ONVO
Current profitability levels for the company are sitting at:
- -123.98 for the present operating margin
- -1.09 for the gross margin
The net margin for Organovo Holdings Inc stands at -121.77. The total capital return value is set at -2.94. Equity return is now at value -206.69, with -140.02 for asset returns.
Currently, EBITDA for the company is -14.81 million with net debt to EBITDA at 0.16. When we switch over and look at the enterprise to sales, we see a ratio of 44.87. The receivables turnover for the company is 3.55for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.98.
Conclusion
To wrap up, the performance of Organovo Holdings Inc (ONVO) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
